Concepedia

Farzan Rastinejad

FR

Statistics

Publications

13

Citations

3.5K

H-Index

13

Active since

1989

Affiliations

Pfizer (United States)(Current)

Stanford University

University of Pennsylvania

Howard Hughes Medical Institute

Northwestern University

Farzan Rastinejad is an author at Pfizer (United States) specializing in oncology, molecular oncology, and life sciences.

Publications per year

1989–2003

13

Publications

13

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Deborah J. Good, Peter J. Polverini, Farzan Rastinejad et al. · Proceedings of the National Academy of Sciences · 1990 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +13

Pharmacological Rescue of Mutant p53 Conformation and Function

Barbara A. Foster, Heather A. Coffey, Michael J. Morin et al. · Science · 1999 · 801 citations

Medicine, Oncology, Pharmacology +13

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene

Farzan Rastinejad, Peter J. Polverini, Noël Bouck · Cell · 1989 · 470 citations

Medicine, Molecular Genetics, Oncology +14

Genetic complementation reveals a novel regulatory role for 3? untranslated regions in growth and differentiation

Farzan Rastinejad · Cell · 1993 · 245 citations

Life Sciences, Genetics, Molecular Genetics +10

Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin

Farzan Rastinejad, Michael J. Conboy, Thomas A. Rando et al. · Cell · 1993 · 201 citations

Life Sciences, Molecular Biology, Oncology +17

1–5 of 13